Navigation Links
Figure Skater Peggy Fleming Teams with HealthSaver: Heart Healthy Living
Date:10/25/2007

blood and causes plaque to form within artery walls, increasing the

risk for blood clots. Smoking also increases the risk of high blood

pressure, stroke and heart disease.

-- The good news is that once you quit, the risk of heart disease

automatically drops. Eventually the risk is the same as if you'd never

smoked. The risk of stroke reaches this level after approximately five

years of breaking the habit.

High Risk Requires Action

-- Diabetics have a higher risk of heart disease, so it's especially

important to control the high blood sugar levels that can damage blood

vessels and lead to stroke and heart attack. If you suffer from

diabetes, take extra care to control your weight and adopt a healthy

lifestyle that includes nutrient-rich foods and plenty of exercise. A

test for diagnostic diabetes every three years will help monitor

glucose levels.

-- The leading cause of the most common form of diabetes is excess weight.

Nearly two-thirds of American adults are overweight. Sustaining a

healthy weight is vital to your heart's health because with the extra

pounds also comes an increased risk of heart failure, high cholesterol,

high blood pressure and stroke. Luckily, shedding even seven pounds

can lower cholesterol levels. To sustain a healthy weight, it's

imperative to pair a well-balanced diet with regular physical activity.

Aim for 30 minutes of exercise per day.

A healthy body requires a healthy heart. To keep this vital organ functioning properly you must avoid harmful habits such as smoking, and adopt a nutritious diet and exercise regimen. Your heart and overall health depend on it.

HealthSaver, an emerging health care discount program, offers savings on prescriptions, vision care, complementary and alternative health care treatments, vitamins and supplemen
'/>"/>

SOURCE HealthSaver
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
2. NHS To Achieve Waiting Figure Target By 2008
3. Boys Join the Race Along With Girl to Get a Stick like Figure
4. Aussie Model Macpherson Hated Tall Figure
5. UNICEF Facts & Figures About Maternal Death In India On The Eve Of Mother’s Da
6. The magic figure for childhood obesity is 11!
7. Bird flu cases in humans: WHO figures
8. Our figures in consonance with UNAIDS estimates : NACO
9. Intestinal Bacteria Blamed for Rotund Figures
10. Uttar Pradesh Dengue Figure Rises to 435
11. Quest for an hour glass figure results in rise of eating disorders by the hour
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Steaz Launches Organic Zero Calorie Sparkling Line 59893 1Steaz Launches Organic Zero Calorie Sparkling Line 59893 2Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2Bioidentical Hormones a True Prevention for Breast Cancer 59889 1Bioidentical Hormones a True Prevention for Breast Cancer 59889 2